Unknown

Dataset Information

0

Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs.


ABSTRACT: Epigenetic silencing of tumor suppressor genes (TSGs) is considered a significant event in the progression of cancer. For example, EPB41L3, a potential biomarker in cervical cancer, is often silenced by cancer-specific promoter methylation. Artificial transcription factors (ATFs) are unique tools to re-express such silenced TSGs to functional levels; however, the induced effects are considered transient. Here, we aimed to improve the efficiency and sustainability of gene re-expression using engineered zinc fingers fused to VP64 (ZF-ATFs) or DNA methylation modifiers (ZF-Tet2 or ZF-TDG) and/or by co-treatment with epigenetic drugs [5-aza-2'-deoxycytidine or Trichostatin A (TSA)]. The EPB41L3-ZF effectively bound its methylated endogenous locus, as also confirmed by ChIP-seq. ZF-ATFs reactivated the epigenetically silenced target gene EPB41L3 (? 10-fold) in breast, ovarian, and cervical cancer cell lines. Prolonged high levels of EPB41L3 (? 150-fold) induction could be achieved by short-term co-treatment with epigenetic drugs. Interestingly, for otherwise ineffective ZF-Tet2 or ZF-TDG treatments, TSA facilitated re-expression of EPB41L3 up to twofold. ATF-mediated re-expression demonstrated a tumor suppressive role for EPB41L3 in cervical cancer cell lines. In conclusion, epigenetic reprogramming provides a novel way to improve sustainability of re-expression of epigenetically silenced promoters.

SUBMITTER: Huisman C 

PROVIDER: S-EPMC4622424 | BioStudies | 2015-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC5528488 | BioStudies
2016-01-01 | S-EPMC5312401 | BioStudies
1000-01-01 | S-EPMC4786921 | BioStudies
2018-01-01 | S-EPMC5851675 | BioStudies
2008-01-01 | S-EPMC4417684 | BioStudies
2019-01-01 | S-EPMC6452588 | BioStudies
2020-01-01 | S-EPMC7218222 | BioStudies
2008-01-01 | S-EPMC2532725 | BioStudies
2016-01-01 | S-EPMC4705393 | BioStudies
1000-01-01 | S-EPMC3919596 | BioStudies